MTHFR C677T AND A1298C GENOTYPES AND HAPLOTYPES
IN SLOVENIAN COUPLES WITH UNEXPLAINED
INFERTILITY PROBLEMS AND IN EMBRYONIC TISSUES
FROM SPONTANEOUS ABORTIONS
Stangler Herodež Š1,*, Zagradišnik B1, Erjavec Škerget A1,
Zagorac A1, Takač I2,3, Vlaisavljević V4, Lokar L5, Kokalj Vokač N1,2
*Corresponding Author: Dr. Špela Stangler Herodež, Laboratory of Medical Genetics, University Clinical Centre
Maribor, Ljubljanska ulica 5, 2000 Maribor, Slovenia; Tel.: 386-2-321-27-37; Fax.: 386-2-321-27-55; E-mail:
spela.sh@ukc-mb.si
page: 31
|
|
REFERENCES
1. de Krester DM. Male infertility. Lancet 1997;
349 (9054): 787-790.
2. Filipponi D, Feil R. Perturbation of genomic imprinting
in oligozoospermia. Epigenetics. 2009;
4(1): 27-30.
3. Boivin J, Bunting L, Collins JA, Nygren K. An
international estimate of infertility prevalence
and treatment-seeking: potential need and demand
for infertility medical care. Hum Reprod.
2007; 22(6): 1506-1512.
4. Jeehyeon B, Seung Joo S, Sun Hee C, Dong Hee
C, Suman L, Nam Keun K. Prevalent genotypes
of methylenetetrahydrofolate reductase (MTHFR
C677T and A1298C) in spontaneously aborted
embryos. Fertil Steril. 2007; 87(2): 351-355. 5. Singh K, Singh SK, Raman R. MTHFR A1298C
polymorphism and idiopathic male infertility. J
Postgrad Med. 2010; 56(4): 267-269.
6. Eloualid A, Abidi O, Charif M, El Houate B, Benrahma
H, Louanjli N, et al. Association of the
MTHFR A1298C variant with unexplained severe
male infertility. PLoS One 2012; 7: e34111.
7. Safarinejad MR, Shafiei N, Safarinejad S. Relationship
between genetic polymorphisms of
methylenetetrahydrofolate reductase (C677T,
A1298C, and G1793A) as risk factors for idiopathic
male infertility. Reprod Sci. 2011; 18(3):
304-315.
8. Ouxi S, Renping L, Wei W, Lugang Y, Xinru W.
Association of the methylenetetrahydrofolate reductase
gene A1298C polymorphism with male
infertility: a meta-analysis. Ann Hum Genet.
2012; 76(1): 25-32.
9. Martinelli I. Risk factors in venous thromboembolism.
Thromb Haemost. 2001; 86(1): 395-403.
10. Fatini C, Gensini F, Battaglini B, Prisco D, Cellai
AP, Fedi S. Angiotensin convertine enzyme
DD genotype, angiotensin type I receptor CC
genotype, and hyperhomo-cysteinemia increase
first-trimester fetal-loss susceptibility. Blood Coagul
Fibrinol. 2000; 11(7): 657-662.
11. Wouters MG, Boers GH, Blom HJ, Trijbels FJ,
Thomas CM, Borm GF. Hyperhomocysteinemia:
a risk factor in woman with unexplained recurrent
early pregnancy loss. Fertil Steril. 1993;
60(5): 820-825.
12. Steegers-Theunissen RP, Boers GH, Trijbels FJ,
Finkelstein JD, Blom HJ, Thomas CM, et al. Maternal
hyperhomocysteinemia: a risk factor for
neural-tube defects? Metabolism. 1994; 43(12):
1475-1480.
13. Coulam CB, Jeyendran RS. Thrombophilic gene
polymorphisms are risk factors for unexplained
infertility. Fertil Steril. 2009; 91(4): 1516-1517.
14. Stegmann K, Ziegler A, Ngo ET, Kohlschmidt N,
Schröter B, Ermert A, et al. Linkage disequilibriumof
MTHFR genotypes 677C/T-1298A/C in
the German population and association studies
in probands with neural tube defects (NTD). Am
J Med Genet. 1999; 87(1): 23-29.
15. Zetterberg H, Regland B, Palmer M, Ricksten
A, Palmqvist L, Rymo L, et al. Increased frequency
of combined methylenetetrahydrofolate
reductase C677T and A1298C mutated alleles
in spontaneously aborted embryos. Eur J Hum
Genet. 2002; 10(2): 113-118.
16. Isotalo PA, Wells GA, Donnelly JG. Neonatal and
fetal methylenetetrahydrofolate reductase genetic
polymorphisms: an examination of C677T
and A1298C mutations. Am J Hum Genet. 2000;
67(4): 986-990.
17. Volcik KA, Blanton SH, Northrup H. Examinations
of methylenetetrahydrofolate reductase
C677T and A1298C mutations – and in utero
viability. Am J Hum Genet. 2001; 69(5): 1150-
1153.
18. Christiansen OB, Nielsen HS, Kolte A, Pedersen
AT. Research methodology and epidemiology
of relevance in recurrent pregnancy loss. Semin
Reprod Med. 2006; 24(1): 5-16.
19. Ren A, Wang J. Methylenetetrahydrofolate reductase
C677T polymorphism and the risk of
unexplained recurrent pregnancy loss: a metaanalysis.
Fertil Steril. 2006; 86(6): 1716-1722.
20. Azem F, Many A, Ben Ami I, Yovel I, Amit A,
Lessing JB, et al. Increased rates of thrombophilia
in woman with repeated IVF failures. Hum
Reprod. 2004; 19(2): 368-370.
21. Qublan HS, Eid SS, Ababnneh HA, Amarin ZO,
Smadi AZ, Al-Khafaji FF, et al. Acquired and
inherited thrombophilia: implication in recurent
IVF and embryo transfer failure. Hum Reprod.
2006; 21(10): 2694-2698.
22. Ogino S, Wilson RB. Genotype and haplotype
distributions of MTHFR 677C>T and 298A>C
single nucleotide polymorphisms: a meta-analysis.
J Hum Genet. 2003; 48(1): 1-7.
23. Miller SA, Dykes DD, Polesky HF. A simple
salting out procedure for extracting DNA from
human nucleated cells. Nucleic Acids Res. 1988;
16(3): 1215.
24. Stangler Herodež Š, Zagradišnik B, Kokalj-Vokač
N. MLPA method for PMP22 gene analysis. Acta
Chim Slov. 2005; 52(2): 105-110.
25. Kovalevsky G, Gracia CR, Berlin JA, Sammel
MD, Barnhart KT. Evaluation of the association between hereditary thrombophilias and recurrent
pregnancy loss: a meta analysis. Acta Intern
Med. 2004; 164(5): 558-563.
26. Freitas AI, Mendonça I, Guerra G, Brión M, Reis
RP, Carracedo A, et al. Methylenetetrahydrofolate
reductase gene, homocysteine and coronary
artery disease: the A1298C polymorphism does
matter: Inferences from a case study (Maderira,
Portugal). Thromb Res. 2008; 122 (5): 648-656.
27. Settin A, Elshazli R, Salama A, El Baz R. Methylenetetrahydrofolate
reductase gene polymorphisms
in Egyptian women with unexplained
recurrent pregnancy loss. Genet Test Mol Biomarkers.
2011; 15(12): 887-892.
28. Rotondo JC, Bosi S, Bazzan E, Di Domenico M,
De Mattei M, Selvatici R, et al. Methylenetetrahydrofolate
reductase gene promoter hypermethylation
in semen samples of infertile couples
correlates with recurrent spontaneous abortion.
Hum Reprod. 2012; 27(12): 3632-3638.
29. Wu W, Shen O, Qin Y, Niu X, Lu C, Xia Y, et al.
Idiopathic male infertility is strongly associated
with aberrant promoter methylation of methylenetetrahydrofolate
reductase (MTHFR). PloS
One 2010; 5: e13884.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
